{"id":79501,"date":"2026-01-02T21:21:50","date_gmt":"2026-01-02T12:21:50","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/serological-testing-market-mordor\/"},"modified":"2026-03-27T09:35:51","modified_gmt":"2026-03-27T00:35:51","slug":"serological-testing-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/serological-testing-market-mordor\/","title":{"rendered":"\u8840\u6e05\u691c\u67fb\u5e02\u5834\uff1a\u5e02\u5834\u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790\u3001\u6210\u9577\u52d5\u5411\u3068\u4e88\u6e2c (2025\u5e74\uff5e2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/serological-testing-market_1655815758664_Screenshot_2022-06-21_181850.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/serological-testing-market-size-image-1735467337389.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \u6162\u6027\u75be\u60a3\u306e\u8ca0\u62c5\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \u597d\u610f\u7684\u306a\u653f\u5e9c\u306e\u53d6\u308a\u7d44\u307f\u3068\u7814\u7a76\u958b\u767a\u6d3b\u52d5\u3078\u306e\u5916\u90e8\u8cc7\u91d1\u306e\u5c0e\u5165<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u53b3\u683c\u306a\u898f\u5236\u30b7\u30ca\u30ea\u30aa\u3068\u511f\u9084\u30dd\u30ea\u30b7\u30fc<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b\u5206\u6790<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.4.1 \u65b0\u898f\u53c2\u5165\u8005\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.2 \u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.3 \u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.5 \u7af6\u4e89\u306e\u6fc0\u3057\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3 (\u91d1\u984d\u5225\u5e02\u5834\u898f\u6a21 &#8211; USD\u767e\u4e07)<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u6280\u8853\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 ELISA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 NAT<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 CLIA\/CMIA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u88fd\u54c1\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u6a5f\u5668<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u6d88\u8017\u54c1\u304a\u3088\u3073\u8a66\u85ac<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \u7528\u9014\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \u809d\u708e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9 (COVID-19)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \u30d2\u30c8\u514d\u75ab\u4e0d\u5168\u30a6\u30a4\u30eb\u30b9 (HIV)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.4 \u30ed\u30bf\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.5 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \u8a3a\u65ad\u691c\u67fb\u6a5f\u95a2<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \u75c5\u9662<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \u305d\u306e\u4ed6\u306e\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.5 \u5730\u57df\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.5.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.3 \u30e1\u30ad\u30b7\u30b3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.2 \u30e8\u30fc\u30ed\u30c3\u30d1<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.1 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.2 \u30a4\u30ae\u30ea\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.4 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.5 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.6 \u305d\u306e\u4ed6\u306e\u30e8\u30fc\u30ed\u30c3\u30d1<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.1 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.2 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.3 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.5 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.4 \u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.5 \u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.1 \u30d6\u30e9\u30b8\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u4e89\u74b0\u5883<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u4f01\u696d\u30d7\u30ed\u30d5\u30a3\u30fc\u30eb<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.1.1 Cellex Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.2 Advanced Diagnostics, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.3 Randox Laboratories Ltd.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.4 Eurofins Scientific<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.5 \u30a2\u30dc\u30c3\u30c8<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.6 \u30d9\u30af\u30c8\u30f3\u30fb\u30c7\u30a3\u30c3\u30ad\u30f3\u30bd\u30f3\u30fb\u30a2\u30f3\u30c9\u30fb\u30ab\u30f3\u30d1\u30cb\u30fc (BD)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.7 \u30af\u30a8\u30b9\u30c8\u30fb\u30c0\u30a4\u30a2\u30b0\u30ce\u30b9\u30c6\u30a3\u30af\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.8 F. \u30db\u30d5\u30de\u30f3\u30fb\u30e9\u30fb\u30ed\u30b7\u30e5\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.9 ELITechGroup<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.10 \u30b5\u30fc\u30e2\u30d5\u30a3\u30c3\u30b7\u30e3\u30fc\u30b5\u30a4\u30a8\u30f3\u30c6\u30a3\u30d5\u30a3\u30c3\u30af\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.11 \u30d9\u30c3\u30af\u30de\u30f3\u30fb\u30b3\u30fc\u30eb\u30bf\u30fc\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.12 BioMedomics Inc.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\u30ea\u30b9\u30c8\u306f\u7db2\u7f85\u7684\u3067\u306f\u3042\u308a\u307e\u305b\u3093 <\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9<\/p>\n<div style=\"font-family: regular_semibold;\">\n    \u7af6\u5408\u60c5\u52e2\u306b\u306f\u3001\u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u6700\u8fd1\u306e\u52d5\u5411\u304c\u542b\u307e\u308c\u307e\u3059\n  <\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306e\u6982\u8981\uff1a\u6210\u9577\u30c8\u30ec\u30f3\u30c9\u3068\u4e88\u6e2c\uff082025\u5e74\uff5e2030\u5e74\uff09<\/p>\n<p>\u306f\u3058\u3081\u306b<\/p>\n<p>\u4e16\u754c\u306e\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff098.8%\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u6280\u8853\uff08ELISA\u3001NAT\u3001CLIA\/CMIA\u306a\u3069\uff09\u3001\u88fd\u54c1\uff08\u6a5f\u5668\u3001\u6d88\u8017\u54c1\u30fb\u8a66\u85ac\uff09\u3001\u7528\u9014\uff08\u809d\u708e\u3001\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\uff08COVID-19\uff09\u3001\u30d2\u30c8\u514d\u75ab\u4e0d\u5168\u30a6\u30a4\u30eb\u30b9\uff08HIV\uff09\u3001\u30ed\u30bf\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306a\u3069\uff09\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\uff08\u8a3a\u65ad\u691c\u67fb\u6a5f\u95a2\u3001\u75c5\u9662\u3001\u305d\u306e\u4ed6\u306e\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\uff09\u3001\u304a\u3088\u3073\u5730\u57df\uff08\u5317\u7c73\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u306a\u3069\uff09\u306b\u57fa\u3065\u3044\u3066\u5e02\u5834\u3092\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u8abf\u67fb\u671f\u9593\u306f2019\u5e74\u304b\u30892030\u5e74\u3001\u63a8\u5b9a\u57fa\u6e96\u5e74\u306f2024\u5e74\u3001\u4e88\u6e2c\u30c7\u30fc\u30bf\u671f\u9593\u306f2025\u5e74\u304b\u30892030\u5e74\u3067\u3059\u3002\u5e02\u5834\u306f\u5317\u7c73\u304c\u6700\u5927\u5e02\u5834\u3067\u3042\u308a\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3059\u308b\u5e02\u5834\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306e\u96c6\u4e2d\u5ea6\u306f\u9ad8\u3044\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u591a\u6570\u306e\u4f01\u696d\u304c\u53c2\u5165\u3057\u3066\u3044\u308b\u305f\u3081\u3001\u5e02\u5834\u306f\u65ad\u7247\u5316\u3055\u308c\u305f\u6027\u8cea\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u6982\u8981<\/p>\n<p>\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306e\u6210\u9577\u306f\u3001\u4e16\u754c\u4e2d\u3067\u5897\u52a0\u3059\u308bCOVID-19\u75c7\u4f8b\u3068\u533b\u7642\u8cbb\u306e\u5897\u52a0\u306b\u3088\u3063\u3066\u727d\u5f15\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u691c\u67fb\u7528\u8840\u6e05\u691c\u67fb\u30ad\u30c3\u30c8\u306e\u4e0d\u8db3\u304c\u5e02\u5834\u6210\u9577\u3092\u963b\u5bb3\u3059\u308b\u8981\u56e0\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u4e00\u65b9\u3067\u3001\u591a\u6570\u306e\u5e02\u5834\u53c2\u5165\u4f01\u696d\u306b\u3088\u308b\u88fd\u54c1\u63d0\u4f9b\u3001COVID\u5206\u6790\u30ad\u30c3\u30c8\u3078\u306e\u7814\u7a76\u958b\u767a\u6295\u8cc7\u306e\u5897\u52a0\u3001\u304a\u3088\u3073\u3053\u306e\u5206\u91ce\u306e\u7814\u7a76\u3092\u652f\u63f4\u3059\u308b\u653f\u5e9c\u306e\u53d6\u308a\u7d44\u307f\u304c\u3001\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306e\u9700\u8981\u3092\u4fc3\u9032\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u7c73\u56fd\u56fd\u7acb\u304c\u3093\u7814\u7a76\u6240\uff08NCI\uff09\u306e\u8840\u6e05\u79d1\u5b66\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\uff08SeroNet\uff09\u306f\u3001COVID-19\u306b\u5bfe\u3059\u308b\u514d\u75ab\u5fdc\u7b54\u3092\u7814\u7a76\u3059\u308b\u305f\u3081\u306e\u7c73\u56fd\u6700\u5927\u306e\u5354\u8abf\u7684\u53d6\u308a\u7d44\u307f\u3067\u3042\u308a\u3001\u8840\u6e05\u691c\u67fb\u304a\u3088\u3073\u95a2\u9023\u6280\u8853\u306e\u958b\u767a\u3001\u691c\u8a3c\u3001\u6539\u5584\u3001\u5b9f\u88c5\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u53d6\u308a\u7d44\u307f\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e02\u5834\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u8840\u6e05\u691c\u67fb\u306f\u3001\u7279\u306b\u591a\u304f\u306e\u611f\u67d3\u304c\u8efd\u5ea6\u307e\u305f\u306f\u7121\u75c7\u72b6\u3067\u3042\u308b\u305f\u3081\u3001SARS-CoV-2\u3078\u306e\u904e\u53bb\u306e\u66dd\u9732\u3092\u7279\u5b9a\u3059\u308b\u305f\u3081\u306e\u8ffd\u52a0\u60c5\u5831\u3092\u63d0\u4f9b\u3059\u308b\u70b9\u3067\u91cd\u8981\u3067\u3059\u3002\u3053\u306e\u691c\u67fb\u306f\u3001\u8840\u6db2\u3001\u8840\u6e05\u3001\u307e\u305f\u306f\u8840\u6f3f\u30b5\u30f3\u30d7\u30eb\u3092\u5206\u6790\u3057\u3001\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\uff08SARS-CoV-2\uff09\u306b\u95a2\u9023\u3059\u308b\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3M\uff08IgM\uff09\u304a\u3088\u3073\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3G\uff08IgG\uff09\u6297\u4f53\u306e\u5b58\u5728\u3092\u691c\u51fa\u3057\u307e\u3059\u3002COVID-19 IgM\u6297\u4f53\u306e\u691c\u51fa\u306f\u6700\u8fd1\u306e\u66dd\u9732\u3092\u793a\u3059\u50be\u5411\u304c\u3042\u308a\u3001COVID-19 IgG\u6297\u4f53\u306e\u691c\u51fa\u306f\u611f\u67d3\u306e\u5f8c\u671f\u6bb5\u968e\u3092\u793a\u3059\u305f\u3081\u3001\u3053\u306e\u7d44\u307f\u5408\u308f\u305b\u6297\u4f53\u691c\u67fb\u306f\u60a3\u8005\u306e\u75be\u60a3\u6bb5\u968e\u306b\u95a2\u3059\u308b\u60c5\u5831\u3082\u63d0\u4f9b\u3067\u304d\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306b\u3001\u4e16\u754c\u7684\u306aCOVID-19\u75c7\u4f8b\u306e\u6025\u5897\u304c\u8840\u6e05\u691c\u67fb\u306e\u9700\u8981\u3092\u62bc\u3057\u4e0a\u3052\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u4e3b\u8981\u4f01\u696d\u306b\u3088\u308bCOVID\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u5371\u6a5f\u3092\u691c\u51fa\u3059\u308b\u305f\u3081\u306e\u88fd\u54c1\u767a\u58f2\u306e\u5897\u52a0\u3082\u3001\u5e02\u5834\u6210\u9577\u306b\u8ca2\u732e\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012020\u5e743\u6708\u306b\u306f\u3001Becton, Dickinson and Company\u3068BioMedomics\u304cCOVID-19\u3078\u306e\u66dd\u9732\u3092\u691c\u51fa\u3059\u308b\u305f\u3081\u306e\u8fc5\u901f\u8840\u6e05\u691c\u67fb\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u30012020\u5e748\u6708\u306b\u306f\u3001Transasia Bio-Medicals\u304c\u30a4\u30f3\u30c9\u5e02\u5834\u3067\u300cErbaLisa COVID-19 IgG ELISA\u300d\u3068\u3044\u3046\u691c\u67fb\u30ad\u30c3\u30c8\u3092\u767a\u58f2\u3057\u3001Promega Corporation\u3082SARS-CoV-2\u30a6\u30a4\u30eb\u30b9\u306b\u5bfe\u3059\u308b\u6297\u4f53\u306e\u5b58\u5728\u3092\u691c\u51fa\u3059\u308b\u65b0\u3057\u3044\u8840\u6e05\u6297\u4f53\u691c\u67fb\u306e\u767a\u58f2\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u3088\u3046\u306b\u3001\u3055\u307e\u3056\u307e\u306a\u7d30\u83cc\u304a\u3088\u3073\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306b\u5bfe\u3059\u308b\u8840\u6e05\u691c\u67fb\u306e\u65b0\u898f\u88fd\u54c1\u958b\u767a\u3068\u627f\u8a8d\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306b\u6210\u9577\u6a5f\u4f1a\u3092\u3082\u305f\u3089\u3059\u3067\u3057\u3087\u3046\u3002<\/p>\n<p>\u52a0\u3048\u3066\u3001\u809d\u708e\u3001\u7d50\u6838\u3001HIV\/AIDS\u306a\u3069\u306e\u611f\u67d3\u75c7\u306e\u4e16\u754c\u7684\u306a\u75c7\u4f8b\u5897\u52a0\u3082\u3001\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306e\u4e3b\u8981\u306a\u727d\u5f15\u5f79\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u7279\u306bC\u578b\u809d\u708e\u611f\u67d3\u306e\u9ad8\u3044\u6709\u75c5\u7387\u306f\u3001\u5bfe\u8c61\u5e02\u5834\u306e\u6210\u9577\u898b\u901a\u3057\u3092\u5e83\u3052\u308b\u4e3b\u8981\u56e0\u306e\u4e00\u3064\u3067\u3059\u3002\u4e16\u754c\u4e2d\u3067\u63a8\u5b9a5,800\u4e07\u4eba\u304c\u6162\u6027C\u578b\u809d\u708e\u30a6\u30a4\u30eb\u30b9\u306b\u611f\u67d3\u3057\u3066\u304a\u308a\u3001\u5e74\u9593\u7d04150\u4e07\u4eba\u306e\u65b0\u898f\u611f\u67d3\u304c\u767a\u751f\u3057\u3066\u3044\u307e\u3059\u3002\u4e16\u754c\u4fdd\u5065\u6a5f\u95a2\uff08WHO\uff09\u306f\u30012019\u5e74\u306b\u306f\u7d0429\u4e07\u4eba\u304cC\u578b\u809d\u708e\u3067\u6b7b\u4ea1\u3057\u3001\u305d\u306e\u307b\u3068\u3093\u3069\u304c\u809d\u786c\u5909\u3084\u809d\u7d30\u80de\u304c\u3093\u306b\u3088\u308b\u3082\u306e\u3068\u63a8\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u809d\u708e\u75c7\u4f8b\u306e\u5897\u52a0\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u3053\u308c\u3089\u306e\u8a3a\u65ad\u691c\u67fb\u306e\u9700\u8981\u3092\u5897\u52a0\u3055\u305b\u3001\u5e02\u5834\u3092\u727d\u5f15\u3059\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u3053\u308c\u3089\u306e\u8981\u56e0\u306b\u3088\u308a\u3001\u8abf\u67fb\u5bfe\u8c61\u5e02\u5834\u306f\u5206\u6790\u671f\u9593\u4e2d\u306b\u6210\u9577\u3092\u9042\u3052\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u53b3\u683c\u306a\u898f\u5236\u30b7\u30ca\u30ea\u30aa\u3068\u511f\u9084\u30dd\u30ea\u30b7\u30fc\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306e\u6210\u9577\u3092\u59a8\u3052\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u691c\u67fb\u7528\u8840\u6e05\u691c\u67fb\u30ad\u30c3\u30c8\u306e\u4e0d\u8db3\u3082\u3001\u5e02\u5834\u6210\u9577\u3078\u306e\u8ab2\u984c\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3068\u6d1e\u5bdf<\/p>\n<p>\u6d88\u8017\u54c1\u3068\u8a66\u85ac\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577<\/p>\n<p>\u6d88\u8017\u54c1\u3068\u8a66\u85ac\u306f\u30012021\u5e74\u306e\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306e\u88fd\u54c1\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u304a\u3044\u3066\u5927\u304d\u306a\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3066\u304a\u308a\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u5e02\u5834\u3067\u6700\u9ad8\u306eCAGR\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u304c\u5927\u304d\u306a\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u6b63\u78ba\u3067\u518d\u73fe\u6027\u306e\u3042\u308b\u7d50\u679c\u3092\u5f97\u308b\u305f\u3081\u306e\u30a2\u30c3\u30bb\u30a4\u306b\u304a\u3051\u308b\u63a1\u7528\u7387\u306e\u9ad8\u3055\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001Thermo Fisher Scientific, Inc.\u306eFisherbrand accuWash\u3084accuWash Versa\u30de\u30a4\u30af\u30ed\u30d7\u30ec\u30fc\u30c8\u30a6\u30a9\u30c3\u30b7\u30e3\u30fc\u306e\u3088\u3046\u306a\u6d88\u8017\u54c1\u306f\u3001ELISA\u3001\u7d30\u80de\u30d9\u30fc\u30b9\u30a2\u30c3\u30bb\u30a4\u3001\u30de\u30a4\u30af\u30ed\u30b9\u30d5\u30a3\u30a2\u30d9\u30fc\u30b9\u30a2\u30c3\u30bb\u30a4\u306a\u3069\u3001\u591a\u304f\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3067\u4f7f\u7528\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30a6\u30a9\u30c3\u30b7\u30e3\u30fc\u306f\u9759\u304b\u3067\u6e05\u6383\u304c\u5bb9\u6613\u3067\u3042\u308a\u3001\u6b8b\u7559\u7269\u3092\u6b8b\u3055\u305a\u3001\u6c5a\u67d3\u3092\u9632\u304e\u3001\u30d0\u30c3\u30af\u30b0\u30e9\u30a6\u30f3\u30c9\u3092\u4f4e\u6e1b\u3057\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306b\u3001\u6d88\u8017\u54c1\u304c\u63d0\u4f9b\u3059\u308b\u5229\u70b9\u304c\u88fd\u54c1\u9700\u8981\u3092\u9ad8\u3081\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u8840\u6e05\u691c\u67fb\u306e\u5897\u52a0\u304c\u6d88\u8017\u54c1\u3068\u8a66\u85ac\u306e\u9700\u8981\u3092\u751f\u307f\u51fa\u3057\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u3055\u3089\u306b\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u4e16\u754c\u4fdd\u5065\u6a5f\u95a2\uff08WHO\uff09\u306e\u30c7\u30fc\u30bf\u306b\u3088\u308b\u3068\u30012020\u5e74\u306e\u8840\u6e05\u691c\u67fb\u7387\u306f2019\u5e74\u3068\u6bd4\u8f03\u3057\u306616.1%\u5897\u52a0\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306b\u3001\u8840\u6e05\u691c\u67fb\u306e\u5897\u52a0\u306f\u3001\u691c\u67fb\u30d7\u30ed\u30bb\u30b9\u306b\u304a\u3051\u308b\u6d88\u8017\u54c1\u3068\u8a66\u85ac\u306e\u5fc5\u8981\u6027\u3092\u751f\u307f\u51fa\u3057\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u53c2\u5165\u4f01\u696d\u306f\u3001\u5e02\u5834\u3067\u306e\u5b58\u5728\u611f\u3092\u9ad8\u3081\u308b\u305f\u3081\u306b\u3001\u65b0\u898f\u88fd\u54c1\u306e\u958b\u767a\u3068\u767a\u58f2\u306b\u7a4d\u6975\u7684\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u307e\u3059\u30022020\u5e74\u306b\u306f\u3001Bio-Rad Laboratories, Inc.\u304c\u3001COVID-19\u306b\u95a2\u9023\u3059\u308b\u30a6\u30a4\u30eb\u30b9\u3067\u3042\u308bSARS-CoV-2\u306e\u6297\u4f53\u691c\u67fb\u306b\u4f7f\u7528\u3059\u308b\u4f53\u5916\u8a3a\u65ad\u7528VIROTROL SARS-CoV-2\u304a\u3088\u3073VIROCLEAR SARS-CoV-2\u967d\u6027\u30fb\u9670\u6027\u54c1\u8cea\u7ba1\u7406\u88fd\u54c1\u306e\u767a\u58f2\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u30012021\u5e74\u306b\u306f\u3001\u30b9\u30da\u30a4\u30f3\u79d1\u5b66\u7814\u7a76\u9ad8\u7b49\u8a55\u8b70\u4f1a\uff08CSIC\uff09\u306e\u7814\u7a76\u8005\u3089\u304c\u30de\u30c9\u30ea\u30fc\u30c9\u306e\u30e9\u30fb\u30d7\u30ea\u30f3\u30bb\u30b5\u75c5\u9662\u304a\u3088\u3073\u30e9\u30fb\u30d1\u30b9\u75c5\u9662\u3068\u5171\u540c\u3067\u958b\u767a\u3057\u3001\u30b9\u30da\u30a4\u30f3\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696dImmunostep\u304c\u88fd\u9020\u3057\u305fCOVID-19\u6297\u4f53\u7528\u306e\u65b0\u3057\u3044\u8840\u6e05\u691c\u67fb\u304c\u5e02\u5834\u306b\u6295\u5165\u3055\u308c\u307e\u3057\u305f\u3002\u3053\u306e\u3088\u3046\u306a\u88fd\u54c1\u767a\u58f2\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u53ce\u76ca\u3092\u5897\u52a0\u3055\u305b\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30e8\u30fc\u30ed\u30c3\u30d1\u5e02\u5834\u306e\u91cd\u8981\u6027<\/p>\n<p>\u30e8\u30fc\u30ed\u30c3\u30d1\u306f\u3001\u611f\u67d3\u75c7\u306e\u6709\u75c5\u7387\u306e\u5897\u52a0\u3001\u78ba\u7acb\u3055\u308c\u305f\u533b\u7642\u30a4\u30f3\u30d5\u30e9\u3001\u304a\u3088\u3073\u5730\u57df\u306b\u304a\u3051\u308b\u9ad8\u9f62\u8005\u4eba\u53e3\u306e\u5897\u52a0\u306b\u3088\u308a\u3001\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306b\u304a\u3044\u3066\u5927\u304d\u306a\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30bb\u30ea\u30a2\u30c3\u30af\u75c5\u306e\u75c7\u4f8b\u5897\u52a0\u3082\u3001\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u727d\u5f15\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012020\u5e74\u306b\u306f\u3001\u6b27\u5dde\u30bb\u30ea\u30a2\u30c3\u30af\u75c5\u5354\u4f1a\uff08AOECS\uff09\u306b\u3088\u308b\u3068\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3067\u306f\u7d04100\u4eba\u306b1\u4eba\u304c\u30bb\u30ea\u30a2\u30c3\u30af\u75c5\u306b\u7f79\u60a3\u3057\u3066\u3044\u308b\u3068\u63a8\u5b9a\u3055\u308c\u307e\u3057\u305f\u3002\u3053\u306e\u6bd4\u7387\u3092\u9069\u7528\u3059\u308b\u3068\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u5168\u4f53\u3067700\u4e07\u4eba\u4ee5\u4e0a\u304c\u30bb\u30ea\u30a2\u30c3\u30af\u75c5\u306e\u5f71\u97ff\u3092\u53d7\u3051\u3066\u3044\u308b\u3068\u4eee\u5b9a\u3055\u308c\u3001\u305d\u306e\u3046\u3061\u8a3a\u65ad\u3092\u53d7\u3051\u3066\u3044\u308b\u306e\u306f\u7d0425%\u306b\u904e\u304e\u307e\u305b\u3093\u3002\u8840\u6e05\u691c\u67fb\u306f\u3001\u30bb\u30ea\u30a2\u30c3\u30af\u75c5\u304c\u7591\u308f\u308c\u308b\u60a3\u8005\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306b\u975e\u5e38\u306b\u6709\u7528\u3067\u3042\u308a\u3001\u5408\u4f75\u75c7\u3092\u9632\u3050\u305f\u3081\u306b\u306f\u65e9\u671f\u8a3a\u65ad\u304c\u4e0d\u53ef\u6b20\u3067\u3059\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u30bb\u30ea\u30a2\u30c3\u30af\u75c5\u306e\u75c7\u4f8b\u5897\u52a0\u306f\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u306b\u304a\u3051\u308b\u5e02\u5834\u6210\u9577\u3092\u3055\u3089\u306b\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>2020\u5e74\u306b\u767a\u8868\u3055\u308c\u305f\u6b27\u5dde\u6162\u6027\u75be\u60a3\u30a2\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u8a18\u4e8b\u306b\u3088\u308b\u3068\u3001\u5fc3\u81d3\u75c5\u3001\u8133\u5352\u4e2d\u3001\u304c\u3093\u3001\u6162\u6027\u547c\u5438\u5668\u75be\u60a3\u3001\u7cd6\u5c3f\u75c5\u306a\u3069\u306e\u6162\u6027\u75be\u60a3\u306f\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u306b\u304a\u3051\u308b\u6b7b\u4ea1\u539f\u56e0\u306e\u5727\u5012\u7684\u306a\u4e3b\u8981\u56e0\u3067\u3042\u308a\u3001\u7dcf\u75be\u60a3\u8ca0\u62c5\u306e77%\u3001\u5168\u6b7b\u4ea1\u306e86%\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u540c\u69d8\u306b\u30012020\u5e74\u306b\u306f\u3001\u6b27\u5dde27\u30ab\u56fd\u3067\u7d04270\u4e07\u4eba\u304c\u304c\u3093\u3068\u8a3a\u65ad\u3055\u308c\u3001\u7d04130\u4e07\u4eba\u304c\u304c\u3093\u3067\u6b7b\u4ea1\u3057\u305f\u3068\u30012020\u5e74\u306b\u5171\u540c\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u304c\u767a\u8868\u3057\u305f\u5831\u544a\u66f8\u306b\u8a18\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306b\u3001\u3053\u306e\u5730\u57df\u306b\u304a\u3051\u308b\u6162\u6027\u75be\u60a3\u306e\u8ca0\u62c5\u5897\u52a0\u304c\u3001\u5730\u57df\u5e02\u5834\u306e\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u3053\u306e\u5730\u57df\u306e\u4e3b\u8981\u4f01\u696d\u306b\u3088\u308b\u88fd\u54c1\u767a\u58f2\u306e\u5897\u52a0\u3082\u3001\u5e02\u5834\u6210\u9577\u3092\u3055\u3089\u306b\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012020\u5e74\u306b\u306f\u3001F. Hoffmann-La Roche Ltd.\u304c\u3001\u91cd\u75c7\u6025\u6027\u547c\u5438\u5668\u75c7\u5019\u7fa4\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b92\uff08SARS-CoV-2\uff09\u306b\u66dd\u9732\u3055\u308c\u305f\u4eba\u3005\u306e\u6297\u4f53\u3092\u691c\u51fa\u3059\u308b\u305f\u3081\u306eElecsys Anti-SARS-CoV-2\u8840\u6e05\u691c\u67fb\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u540c\u69d8\u306b\u30012020\u5e745\u6708\u306b\u306f\u3001IDvet\u304cCOVID-19\u306b\u5bfe\u3059\u308b\u6297\u4f53\u3092\u691c\u51fa\u3059\u308b\u65b0\u3057\u3044\u8840\u6e05\u691c\u67fb\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u8a3a\u65ad\u30ad\u30c3\u30c8\u306fELISA\u6280\u8853\u306b\u57fa\u3065\u3044\u3066\u304a\u308a\u3001\u691c\u67fb\u6a5f\u95a2\u3067\u306e\u5927\u91cf\u691c\u67fb\u5411\u3051\u306b\u8a2d\u8a08\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u307e\u305f\u30012020\u5e744\u6708\u306b\u306f\u3001Eurofins Technologies\u304c\u3001COVID-19\u306b\u66dd\u9732\u3055\u308c\u305f\u60a3\u8005\u306eELISA\u306b\u3088\u308b\u8840\u6e05\u30d9\u30fc\u30b9\u306e\u6297\u4f53\u691c\u51fa\u7528\u691c\u67fb\u30ad\u30c3\u30c8\u306e\u6700\u521d\u306e\u30b7\u30ea\u30fc\u30ba\u306b\u3064\u3044\u3066CE-IVD\u30de\u30fc\u30af\u306e\u53d6\u5f97\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u3089\u306e\u30a2\u30c3\u30bb\u30a4\u306e\u958b\u767a\u306f\u3001\u95a2\u9023\u4f1a\u793e\u3067\u3042\u308bGold Standard Diagnostics Inc.\u3001ENVIROTECH Diagnostics GmbH\u3001NovaTec Immundiagnostica GmbH\u3001\u304a\u3088\u3073Ingenasa\uff08Inmunologia Y Genetica Aplicada SA\uff09\u304c\u4e3b\u5c0e\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u3088\u3046\u306b\u3001\u3055\u307e\u3056\u307e\u306a\u7d30\u83cc\u304a\u3088\u3073\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306b\u5bfe\u3059\u308b\u8840\u6e05\u691c\u67fb\u306e\u65b0\u898f\u767a\u58f2\u306e\u5897\u52a0\u306f\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u5730\u57df\u306e\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306b\u6210\u9577\u6a5f\u4f1a\u3092\u3082\u305f\u3089\u3059\u3067\u3057\u3087\u3046\u3002<\/p>\n<p>\u3057\u305f\u304c\u3063\u3066\u3001\u3053\u308c\u3089\u306e\u8981\u56e0\u306b\u3088\u308a\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u5730\u57df\u306b\u304a\u3051\u308b\u8abf\u67fb\u5bfe\u8c61\u5e02\u5834\u306e\u6210\u9577\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u5408\u72b6\u6cc1<\/p>\n<p>\u8840\u6e05\u691c\u67fb\u5e02\u5834\u306f\u3001\u4e16\u754c\u304a\u3088\u3073\u5730\u57df\u3067\u4e8b\u696d\u3092\u5c55\u958b\u3059\u308b\u591a\u6570\u306e\u4f01\u696d\u304c\u5b58\u5728\u3059\u308b\u305f\u3081\u3001\u65ad\u7247\u5316\u3055\u308c\u305f\u6027\u8cea\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002\u7af6\u5408\u72b6\u6cc1\u306b\u306f\u3001\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u4fdd\u6301\u3057\u3001\u3088\u304f\u77e5\u3089\u308c\u3066\u3044\u308b\u3044\u304f\u3064\u304b\u306e\u56fd\u969b\u4f01\u696d\u304a\u3088\u3073\u5730\u5143\u4f01\u696d\u306e\u5206\u6790\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u4e3b\u8981\u4f01\u696d\u306b\u306f\u3001Cellex Inc.\u3001Advanced Diagnostics, Inc.\u3001Randox Laboratories Ltd.\u3001Eurofins Scientific\u3001Abbott\u3001Becton, Dickinson and Company (BD)\u3001Quest Diagnostics\u3001F. Hoffmann La-Roche Ltd\u3001BioMedomics Inc.\u3001Beckman Coulter, Inc.\u3001\u304a\u3088\u3073Thermo Fisher Scientific, Inc.\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u7279\u306b\u3001F. Hoffmann La-Roche Ltd\u3001Thermo Fisher Scientific, Inc.\u3001Beckman Coulter, Inc.\u3001ELITechGroup\u3001Becton, Dickinson and Company (BD)\u306a\u3069\u304c\u696d\u754c\u306e\u4e3b\u8981\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u8a8d\u8b58\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<\/p>\n<p>*   2020\u5e744\u6708\u3001Accelerate Diagnostics\u3068BioCheck\u306f\u3001MS-FAST\u5316\u5b66\u767a\u5149\u514d\u75ab\u6e2c\u5b9a\u5206\u6790\u88c5\u7f6e\u304a\u3088\u3073SARS-CoV-2\u6297\u4f53\u691c\u67fb\u306e\u8ca9\u58f2\u306b\u95a2\u3059\u308b\u63d0\u643a\u5951\u7d04\u3092\u7de0\u7d50\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2020\u5e743\u6708\u3001Chembio Diagnostic Systems Inc.\u306f\u3001DPP COVID-19\u8840\u6e05\u5b66\u7684\u30dd\u30a4\u30f3\u30c8\u30aa\u30d6\u30b1\u30a2\u691c\u67fb\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u8840\u6e05\u5b66\u7684\u691c\u67fb\u306e\u4e16\u754c\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u8840\u6e05\u5b66\u7684\u691c\u67fb\u306f\u3001\u8840\u6db2\u30b5\u30f3\u30d7\u30eb\u3092\u7528\u3044\u3066\u30a6\u30a4\u30eb\u30b9\u306b\u5bfe\u3059\u308b\u6297\u4f53\u306e\u6709\u7121\u3092\u691c\u51fa\u3059\u308b\u533b\u7642\u691c\u67fb\u306e\u4e00\u7a2e\u3067\u3042\u308a\u3001\u611f\u67d3\u75c7\u306e\u8a3a\u65ad\u3084\u514d\u75ab\u72b6\u614b\u306e\u8a55\u4fa1\u306b\u4e0d\u53ef\u6b20\u306a\u6280\u8853\u3067\u3059\u3002<\/p>\n<p>\u672c\u8abf\u67fb\u306e\u7bc4\u56f2\u306f\u5e83\u7bc4\u306b\u308f\u305f\u308a\u3001\u5e02\u5834\u306f\u4ee5\u4e0b\u306e\u4e3b\u8981\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u5206\u985e\u3055\u308c\u3001\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n1.  \u6280\u8853\u5225: ELISA\u3001NAT\uff08\u6838\u9178\u5897\u5e45\u691c\u67fb\uff09\u3001CLIA\/CMIA\uff08\u5316\u5b66\u767a\u5149\u514d\u75ab\u6e2c\u5b9a\u6cd5\/\u5316\u5b66\u767a\u5149\u30de\u30a4\u30af\u30ed\u7c92\u5b50\u514d\u75ab\u6e2c\u5b9a\u6cd5\uff09\u3001\u305d\u306e\u4ed6\u3002<br \/>\n2.  \u88fd\u54c1\u5225: \u691c\u67fb\u6a5f\u5668\u3001\u6d88\u8017\u54c1\u304a\u3088\u3073\u8a66\u85ac\u3002<br \/>\n3.  \u7528\u9014\u5225: \u809d\u708e\u3001\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\uff08COVID-19\uff09\u3001\u30d2\u30c8\u514d\u75ab\u4e0d\u5168\u30a6\u30a4\u30eb\u30b9\uff08HIV\uff09\u3001\u30ed\u30bf\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u3001\u305d\u306e\u4ed6\u3002<br \/>\n4.  \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225: \u8a3a\u65ad\u691c\u67fb\u6a5f\u95a2\u3001\u75c5\u9662\u3001\u305d\u306e\u4ed6\u306e\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u3002<br \/>\n5.  \u5730\u57df\u5225: \u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30e1\u30ad\u30b7\u30b3\uff09\u3001\u6b27\u5dde\uff08\u30c9\u30a4\u30c4\u3001\u82f1\u56fd\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u305d\u306e\u4ed6\u6b27\u5dde\uff09\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff08\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u97d3\u56fd\u3001\u305d\u306e\u4ed6\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff09\u3001\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\uff08GCC\u8af8\u56fd\u3001\u5357\u30a2\u30d5\u30ea\u30ab\u3001\u305d\u306e\u4ed6\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\uff09\u3001\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u3001\u305d\u306e\u4ed6\u5357\u7c73\uff09\u3002<\/p>\n<p>\u3053\u308c\u3089\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u57fa\u3065\u304d\u3001\u4e16\u754c17\u30ab\u56fd\u306e\u5e02\u5834\u898f\u6a21\u3068\u30c8\u30ec\u30f3\u30c9\u304c\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u4e3b\u8981\u306a\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u6162\u6027\u75be\u60a3\u306e\u8ca0\u62c5\u5897\u52a0\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u4e16\u754c\u7684\u306b\u6162\u6027\u75be\u60a3\u306e\u7f79\u60a3\u7387\u304c\u9ad8\u307e\u308b\u4e2d\u3001\u65e9\u671f\u8a3a\u65ad\u3068\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u306e\u5fc5\u8981\u6027\u304c\u8840\u6e05\u5b66\u7684\u691c\u67fb\u306e\u9700\u8981\u3092\u62bc\u3057\u4e0a\u3052\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u653f\u5e9c\u306b\u3088\u308b\u597d\u610f\u7684\u306a\u53d6\u308a\u7d44\u307f\u3084\u3001\u7814\u7a76\u958b\u767a\u6d3b\u52d5\u3078\u306e\u5916\u90e8\u8cc7\u91d1\u63d0\u4f9b\u3082\u5e02\u5834\u62e1\u5927\u306b\u5927\u304d\u304f\u8ca2\u732e\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u652f\u63f4\u306f\u3001\u65b0\u3057\u3044\u691c\u67fb\u6280\u8853\u306e\u958b\u767a\u3084\u666e\u53ca\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3082\u5b58\u5728\u3057\u307e\u3059\u3002\u7279\u306b\u3001\u53b3\u683c\u306a\u898f\u5236\u30b7\u30ca\u30ea\u30aa\u3068\u511f\u9084\u30dd\u30ea\u30b7\u30fc\u306f\u3001\u65b0\u3057\u3044\u691c\u67fb\u88fd\u54c1\u306e\u5e02\u5834\u5c0e\u5165\u3092\u9045\u3089\u305b\u305f\u308a\u3001\u533b\u7642\u6a5f\u95a2\u3067\u306e\u63a1\u7528\u3092\u5236\u9650\u3057\u305f\u308a\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883\u306e\u5206\u6790\u306b\u306f\u3001\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\u304c\u7528\u3044\u3089\u308c\u3066\u304a\u308a\u3001\u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01\u3001\u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u4ea4\u6e09\u529b\u3001\u4ee3\u66ff\u54c1\u306e\u8105\u5a01\u3001\u7af6\u4e89\u306e\u6fc0\u3057\u3055\u3068\u3044\u3063\u305f\u5074\u9762\u304b\u3089\u5e02\u5834\u306e\u69cb\u9020\u304c\u8a55\u4fa1\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306e\u4e3b\u8981\u306a\u8abf\u67fb\u7d50\u679c\u3068\u3057\u3066\u3001\u4e16\u754c\u306e\u8840\u6e05\u5b66\u7684\u691c\u67fb\u5e02\u5834\u306f\u3001\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u306b\u304a\u3044\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff098.8%\u3067\u7740\u5b9f\u306b\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5730\u57df\u5225\u306b\u898b\u308b\u3068\u30012025\u5e74\u306b\u306f\u5317\u7c73\u304c\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u5148\u9032\u7684\u306a\u533b\u7642\u30a4\u30f3\u30d5\u30e9\u3001\u9ad8\u3044\u533b\u7642\u8cbb\u652f\u51fa\u3001\u304a\u3088\u3073\u4e3b\u8981\u4f01\u696d\u306e\u5b58\u5728\u306b\u8d77\u56e0\u3059\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002\u4e00\u65b9\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u6700\u3082\u9ad8\u3044CAGR\u3067\u6210\u9577\u3059\u308b\u5730\u57df\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002\u3053\u308c\u306f\u3001\u533b\u7642\u30a2\u30af\u30bb\u30b9\u306e\u6539\u5584\u3001\u6162\u6027\u75be\u60a3\u306e\u5897\u52a0\u3001\u304a\u3088\u3073\u653f\u5e9c\u306e\u533b\u7642\u6295\u8cc7\u306e\u62e1\u5927\u304c\u80cc\u666f\u306b\u3042\u308b\u3068\u63a8\u6e2c\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306b\u304a\u3051\u308b\u4e3b\u8981\u306a\u30d7\u30ec\u30a4\u30e4\u30fc\u3068\u3057\u3066\u306f\u3001F. Hoffmann La-Roche Ltd\u3001Thermo Fisher Scientific, Inc.\u3001Beckman Coulter, Inc.\u3001ELITechGroup\u3001Becton, Dickinson and Company (BD)\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u4f01\u696d\u306f\u3001\u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u72b6\u6cc1\u3001\u88fd\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3001\u6226\u7565\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u3068\u3044\u3063\u305f\u89b3\u70b9\u304b\u3089\u8a73\u7d30\u306b\u30d7\u30ed\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\u3055\u308c\u3066\u304a\u308a\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u7af6\u4e89\u529b\u3068\u52d5\u5411\u304c\u660e\u3089\u304b\u306b\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u30012019\u5e74\u304b\u30892024\u5e74\u307e\u3067\u306e\u904e\u53bb\u306e\u5e02\u5834\u898f\u6a21\u30c7\u30fc\u30bf\u3068\u30012025\u5e74\u304b\u30892030\u5e74\u307e\u3067\u306e\u5e02\u5834\u4e88\u6e2c\u3092\u63d0\u4f9b\u3057\u3001\u5e02\u5834\u306e\u5168\u4f53\u50cf\u3068\u5c06\u6765\u306e\u5c55\u671b\u3092\u7406\u89e3\u3059\u308b\u305f\u3081\u306e\u8cb4\u91cd\u306a\u60c5\u5831\u6e90\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/79501"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=79501"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/79501\/revisions"}],"predecessor-version":[{"id":79504,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/79501\/revisions\/79504"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=79501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=79501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=79501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}